nCoV vaccine: Trials of Sputnik V begin in India
Follow The Hawk on Google News+ FollowAdvertisement

New Delhi: Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organization's Drug Controller General (DCGI) has said.
The organisation has granted permission for conducting the tests to pharmaceutical giant Dr Reddy's Laboratories.
Advertisement
The date and timing of the testing will be determined by the company, the DCGI said.
Also readFSSAI to initiate action against Bisleri over unsafe water sample
The vaccine will be tested in the second phase of its clinical trials before moving on to phase 3.
Last week, the Russian Direct Investment Fund (RDIF) and Dr Reddy's said that they had received approval from the DCGI to conduct phase 2 and 3 of clinical trials of Sputnik V. The RDIF and Dr Reddy's have entered into a partnership to supply the Indian company with 100 million doses of Sputnik V in September.
Advertisement
On Monday, the RDIF and another Indian pharmaceutical company, Mankind Pharma, signed an agreement for the marketing and distribution of Sputnik V.
Russia registered the world's first coronavirus vaccine, developed by the Gamaleya Institute together with RDIF, in August. The fund has been teaming up with partners to conduct Sputnik V clinical trials in Belarus, Venezuela and the United Arab Emirates.
—UNI
Get The Hawk first on Google
Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.
Advertisement








